Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Castillo

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Medical Clinics of North America|October 30, 2012
Endocrine and metabolic changes during sepsis: an updateRomesh Khardori, Danielle Castillo
JCO Precision Oncology|January 7, 2022
Evaluation of <i>TP53</i> Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic <i>TP53</i> VariantsAlison N Schwartz, Sophie R Hyman, Samantha M Stokes, et al.
Journal of Geriatric Oncology|October 3, 2019
Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesisThomas P Slavin, Can-Lan Sun, Yanin Chavarri-Guerra, et al.
Cancer Genetics|April 29, 2017
Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndromeAnnette Y Sunga, Charité Ricker, Carin R Espenschied, et al.
Clinical Genitourinary Cancer|June 28, 2023
Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate CancerYanin Chávarri-Guerra, María T Bourlon, José L Rodríguez-Olivares, et al.
Cancer|September 20, 2014
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in MexicoCynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, et al.
JCO Global Oncology|June 28, 2021
Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in MexicoKathleen R Blazer, Yanin Chavarri-Guerra, Cynthia Villarreal Garza, et al.
Journal of the Endocrine Society|June 25, 2021
A Novel, Likely Pathogenic <i>MAX</i> Germline Variant in a Patient With Unilateral PheochromocytomaCésar Ernesto Lam-Chung, Larissa López Rodríguez, Jazmín Arteaga Vázquez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 StatusDanielle Castillo, Tze-An Yuan, Bita Nehoray, et al.
Cancer|June 18, 2019
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancerJeffrey N Weitzel, Susan L Neuhausen, Aaron Adamson, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Medical Clinics of North America|October 30, 2012
Endocrine and metabolic changes during sepsis: an updateRomesh Khardori, Danielle Castillo
JCO Precision Oncology|January 7, 2022
Evaluation of <i>TP53</i> Variants Detected on Peripheral Blood or Saliva Testing: Discerning Germline From Somatic <i>TP53</i> VariantsAlison N Schwartz, Sophie R Hyman, Samantha M Stokes, et al.
Journal of Geriatric Oncology|October 3, 2019
Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesisThomas P Slavin, Can-Lan Sun, Yanin Chavarri-Guerra, et al.
Cancer Genetics|April 29, 2017
Spectrum of mismatch repair gene mutations and clinical presentation of Hispanic individuals with Lynch syndromeAnnette Y Sunga, Charité Ricker, Carin R Espenschied, et al.
Clinical Genitourinary Cancer|June 28, 2023
Germline DNA Repair Genes Pathogenic Variants Among Mexican Patients With Prostate CancerYanin Chávarri-Guerra, María T Bourlon, José L Rodríguez-Olivares, et al.
Cancer|September 20, 2014
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in MexicoCynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, et al.
JCO Global Oncology|June 28, 2021
Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in MexicoKathleen R Blazer, Yanin Chavarri-Guerra, Cynthia Villarreal Garza, et al.
Journal of the Endocrine Society|June 25, 2021
A Novel, Likely Pathogenic <i>MAX</i> Germline Variant in a Patient With Unilateral PheochromocytomaCésar Ernesto Lam-Chung, Larissa López Rodríguez, Jazmín Arteaga Vázquez, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 2, 2022
Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 StatusDanielle Castillo, Tze-An Yuan, Bita Nehoray, et al.
Cancer|June 18, 2019
Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancerJeffrey N Weitzel, Susan L Neuhausen, Aaron Adamson, et al.
Pageof 2